Natural Capsules reported mixed Q1 financial results. Standalone performance showed growth with Rs 44.24 crore revenue and Rs 2.52 crore net profit. Consolidated results reflected challenges, with Rs 45.20 crore revenue but Rs 5.58 crore net loss. The Capsules segment remained profitable, while the new API segment incurred significant losses. The subsidiary, Natural Biogenex Private Limited, started operations recently and is yet to reach full revenue potential.